Difficulty: Medium
Average Score: 66%
Practice
Which hypolipidemic drug has been used to control and prevent pancreatitis in familial hypertriglyceridemia?
Correct answer
D
Rationale
In the context of familial hypertriglyceridemia, the correct answer is option D) Nicotinic acid. Nicotinic acid, also known as niacin, is a hypolipidemic agent that has been shown to effectively reduce triglyceride levels, thereby helping to prevent pancreatitis in individuals with familial hypertriglyceridemia. Niacin works by inhibiting the release of free fatty acids from adipose tissue, which in turn reduces the synthesis of triglycerides in the liver.
Option A) Lovastatin is a statin drug that primarily works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis. While statins are effective in lowering LDL cholesterol levels, they are not as effective in reducing triglyceride levels compared to niacin.
Option B) Clofibrate is a fibric acid derivative that primarily reduces triglyceride levels by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha). However, it is not the drug of choice for preventing pancreatitis in familial hypertriglyceridemia.
Option C) Cholestyramine is a bile acid sequestrant that works by binding bile acids in the intestine, leading to increased excretion of bile acids and cholesterol. It is effective in lowering LDL cholesterol levels but is not specifically indicated for reducing triglyceride levels to prevent pancreatitis in familial hypertriglyceridemia.
Educationally, understanding the mechanism of action of different hypolipidemic agents is crucial in determining the appropriate treatment for specific lipid disorders. Knowing the specific indications and contraindications of each drug allows healthcare providers to make informed decisions regarding patient care and treatment plans. In the case of familial hypertriglyceridemia and pancreatitis prevention, niacin's ability to lower triglyceride levels makes it the preferred choice among the options provided.
Option A) Lovastatin is a statin drug that primarily works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis. While statins are effective in lowering LDL cholesterol levels, they are not as effective in reducing triglyceride levels compared to niacin.
Option B) Clofibrate is a fibric acid derivative that primarily reduces triglyceride levels by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha). However, it is not the drug of choice for preventing pancreatitis in familial hypertriglyceridemia.
Option C) Cholestyramine is a bile acid sequestrant that works by binding bile acids in the intestine, leading to increased excretion of bile acids and cholesterol. It is effective in lowering LDL cholesterol levels but is not specifically indicated for reducing triglyceride levels to prevent pancreatitis in familial hypertriglyceridemia.
Educationally, understanding the mechanism of action of different hypolipidemic agents is crucial in determining the appropriate treatment for specific lipid disorders. Knowing the specific indications and contraindications of each drug allows healthcare providers to make informed decisions regarding patient care and treatment plans. In the case of familial hypertriglyceridemia and pancreatitis prevention, niacin's ability to lower triglyceride levels makes it the preferred choice among the options provided.